248 related articles for article (PubMed ID: 29943822)
1. Randomised study of HPV prevalence and detection of CIN2+ in vaginal self-sampling compared to cervical specimens collected by medical personnel.
Gustavsson I; Aarnio R; Berggrund M; Hedlund-Lindberg J; Sanner K; Wikström I; Enroth S; Olovsson M; Gyllensten U
Int J Cancer; 2019 Jan; 144(1):89-97. PubMed ID: 29943822
[TBL] [Abstract][Full Text] [Related]
2. Comparison of vaginal self-sampling and cervical sampling by medical professionals for the detection of HPV and CIN2+: A randomized study.
Aarnio R; Isacson I; Sanner K; Gustavsson I; Gyllensten U; Olovsson M
Int J Cancer; 2021 Jun; 148(12):3051-3059. PubMed ID: 33497465
[TBL] [Abstract][Full Text] [Related]
3. Randomised study shows that repeated self-sampling and HPV test has more than two-fold higher detection rate of women with CIN2+ histology than Pap smear cytology.
Gustavsson I; Aarnio R; Berggrund M; Hedlund-Lindberg J; Strand AS; Sanner K; Wikström I; Enroth S; Olovsson M; Gyllensten U
Br J Cancer; 2018 Mar; 118(6):896-904. PubMed ID: 29438367
[TBL] [Abstract][Full Text] [Related]
4. Short-time repeat high-risk HPV testing by self-sampling for screening of cervical cancer.
Gyllensten U; Sanner K; Gustavsson I; Lindell M; Wikström I; Wilander E
Br J Cancer; 2011 Aug; 105(5):694-7. PubMed ID: 21811250
[TBL] [Abstract][Full Text] [Related]
5. Self-sampling of vaginal fluid and high-risk human papillomavirus testing in women aged 50 years or older not attending Papanicolaou smear screening.
Lindell M; Sanner K; Wikström I; Wilander E
BJOG; 2012 Jan; 119(2):245-8. PubMed ID: 22017806
[TBL] [Abstract][Full Text] [Related]
6. Type-specific detection of high-risk human papillomavirus (HPV) in self-sampled cervicovaginal cells applied to FTA elute cartridge.
Gustavsson I; Sanner K; Lindell M; Strand A; Olovsson M; Wikström I; Wilander E; Gyllensten U
J Clin Virol; 2011 Aug; 51(4):255-8. PubMed ID: 21632283
[TBL] [Abstract][Full Text] [Related]
7. Primary high-risk HPV screening for cervical cancer in post-menopausal women.
Gyllensten U; Gustavsson I; Lindell M; Wilander E
Gynecol Oncol; 2012 May; 125(2):343-5. PubMed ID: 22293044
[TBL] [Abstract][Full Text] [Related]
8. Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial.
Elfström KM; Smelov V; Johansson AL; Eklund C; Nauclér P; Arnheim-Dahlström L; Dillner J
BMJ; 2014 Jan; 348():g130. PubMed ID: 24435414
[TBL] [Abstract][Full Text] [Related]
9. HPV testing in first-void urine provides sensitivity for CIN2+ detection comparable with a smear taken by a clinician or a brush-based self-sample: cross-sectional data from a triage population.
Leeman A; Del Pino M; Molijn A; Rodriguez A; Torné A; de Koning M; Ordi J; van Kemenade F; Jenkins D; Quint W
BJOG; 2017 Aug; 124(9):1356-1363. PubMed ID: 28391609
[TBL] [Abstract][Full Text] [Related]
10. Pooled analysis of a self-sampling HPV DNA Test as a cervical cancer primary screening method.
Zhao FH; Lewkowitz AK; Chen F; Lin MJ; Hu SY; Zhang X; Pan QJ; Ma JF; Niyazi M; Li CQ; Li SM; Smith JS; Belinson JL; Qiao YL; Castle PE
J Natl Cancer Inst; 2012 Feb; 104(3):178-88. PubMed ID: 22271765
[TBL] [Abstract][Full Text] [Related]
11. Equal prevalence of severe cervical dysplasia by HPV self-sampling and by midwife-collected samples for primary HPV screening: a randomised controlled trial.
Hellsten C; Ernstson A; Bodelsson G; Forslund O; Borgfeldt C
Eur J Cancer Prev; 2021 Jul; 30(4):334-340. PubMed ID: 34010238
[TBL] [Abstract][Full Text] [Related]
12. Clinical validation of the HPVIR high-risk HPV test on cervical samples according to the international guidelines for human papillomavirus DNA test requirements for cervical cancer screening.
Gustavsson I; Aarnio R; Myrnäs M; Hedlund-Lindberg J; Taku O; Meiring T; Wikström I; Enroth S; Williamson AL; Olovsson M; Gyllensten U
Virol J; 2019 Aug; 16(1):107. PubMed ID: 31438976
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness analysis of repeated self-sampling for HPV testing in primary cervical screening: a randomized study.
Aarnio R; Östensson E; Olovsson M; Gustavsson I; Gyllensten U
BMC Cancer; 2020 Jul; 20(1):645. PubMed ID: 32660432
[TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of high-risk HPV detection on self-samples using the indicating FTA-elute solid-carrier cartridge.
Geraets DT; van Baars R; Alonso I; Ordi J; Torné A; Melchers WJ; Meijer CJ; Quint WG
J Clin Virol; 2013 Jun; 57(2):125-9. PubMed ID: 23518442
[TBL] [Abstract][Full Text] [Related]
15. Community-randomised controlled trial embedded in the Anishinaabek Cervical Cancer Screening Study: human papillomavirus self-sampling versus Papanicolaou cytology.
Zehbe I; Jackson R; Wood B; Weaver B; Escott N; Severini A; Krajden M; Bishop L; Morrisseau K; Ogilvie G; Burchell AN; Little J
BMJ Open; 2016 Oct; 6(10):e011754. PubMed ID: 27855089
[TBL] [Abstract][Full Text] [Related]
16. Validation of a new HPV self-sampling device for cervical cancer screening: The Cervical and Self-Sample In Screening (CASSIS) study.
El-Zein M; Bouten S; Louvanto K; Gilbert L; Gotlieb W; Hemmings R; Behr MA; Franco EL;
Gynecol Oncol; 2018 Jun; 149(3):491-497. PubMed ID: 29678360
[TBL] [Abstract][Full Text] [Related]
17. Long term results of follow-up after HPV self-sampling with devices Qvintip and HerSwab in women non-attending cervical screening programme.
Bokan T; Ivanus U; Jerman T; Takac I; Arko D
Radiol Oncol; 2021 Jan; 55(2):187-195. PubMed ID: 33764704
[TBL] [Abstract][Full Text] [Related]
18. Comparative Assessment of a Self-sampling Device and Gynecologist Sampling for Cytology and HPV DNA Detection in a Rural and Low Resource Setting: Malaysian Experience.
Latiff LA; Ibrahim Z; Pei CP; Rahman SA; Akhtari-Zavare M
Asian Pac J Cancer Prev; 2015; 16(18):8495-501. PubMed ID: 26745108
[TBL] [Abstract][Full Text] [Related]
19. [Health technology assessment report. Use of liquid-based cytology for cervical cancer precursors screening].
Ronco G; Confortini M; Maccallini V; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Giorgi Rossi P
Epidemiol Prev; 2012; 36(5 Suppl 2):e1-e33. PubMed ID: 23139163
[TBL] [Abstract][Full Text] [Related]
20. Type-specific human papillomavirus DNA testing with the genotyping array: a comparison of cervical and vaginal sampling.
Twu NF; Yen MS; Lau HY; Chen YJ; Yu BK; Lin CY
Eur J Obstet Gynecol Reprod Biol; 2011 May; 156(1):96-100. PubMed ID: 21288625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
